Senate Democrats have expressed concerns regarding Health and Human Services Secretary Robert F. Kennedy Jr. and his handling of financial interests in a vaccine lawsuit. Discrepancies in Kennedy’s financial disclosures prompted inquiries. The questions arise from Kennedy’s involvement in a lawsuit by law firm Wisner Baum against Merck, focusing on alleged injuries from the HPV vaccine, Gardasil.
Merck settled the lawsuit earlier this year with a $50 million payment, asserting the vaccine’s safety and effectiveness while admitting no wrongdoing. Wisner Baum announced Kennedy and his son would not benefit from the settlement, contradicting Kennedy’s previous statements to Congress regarding his divestment.
Kennedy initially planned to transfer his interests to his son, yet in May, HHS indicated those interests were reassigned to Wisner Baum, confirmed by the firm. The differing accounts led Senators Elizabeth Warren, Ron Wyden, Richard Blumenthal, and Angela Alsobrooks to question the conditions of Kennedy’s decision to revert stakes to Wisner Baum. They urged Kennedy to clarify whether additional perks or benefits might ensue post-government service.
HHS Senior Press Secretary Emily Hilliard maintained that Kennedy complied with ethical guidelines, eliminating any financial interests related to Gardasil lawsuits before his role as Secretary. Congress was assured of Kennedy’s adherence by HHS ethics officials.
In other healthcare updates, researchers at UC San Diego have identified a peptide, catestatin or CST, potentially offering new treatment avenues for Alzheimer’s and other neurological disorders.
Senator Susan Collins urged the Trump administration to utilize over $1 billion in global health funding before its expiration. Meanwhile, Pentagon officials aim to advance President Trump’s substantial defense budget request amid concerns over timely lobbying efforts.
Healthcare-related headlines include renewed measles cases in the U.S., candidates vying for the WHO leadership, and Florida states of emergency due to dengue fever.